In situ surface modification on dental composite resin using 2-methacryloyloxyethyl phosphorylcholine (cas 107-73-3) polymer for controlling plaque formation
-
Add time:08/25/2019 Source:sciencedirect.com
Composite resins (CRs) are widely used as dental restorative materials for caries treatment. They cause problems of secondary caries since Streptococcus mutans stays in the dental plaque, which the surface exists and produces acidic compounds during metabolism. The dental plaque depositions are induced by the protein adsorption on the surface. Therefore, suppression of protein adsorption on the surface of the CRs is important for inhibiting the formation of plaque and secondary caries. In this study we developed a surface treatment to provide an antibiofouling nature to the CRs by chemical reaction with 2-methacryloyloxyethyl phosphorylcholine (cas 107-73-3) (MPC) polymers in the oral cavity during dental treatment. To carry out the photochemical reaction on the remaining polymerizable groups of CRs, we synthesized the MPC polymer with a polymerizable group in the side chain. The MPC polymer could bind on the surfaces of the CRs chemically under dental treatment procedures. The treated surface showed significant resistance to oral protein adsorption and bacterial adhesion even when the surface was brushed with a toothbrush. Thus, we concluded that the photochemical reaction of the MPC polymer with the CRs in the oral cavity was good for making an antibiofouling surface and preventing secondary caries.
We also recommend Trading Suppliers and Manufacturers of phosphorylcholine (cas 107-73-3). Pls Click Website Link as below: cas 107-73-3 suppliers
Prev:ProtocolsBiocompatible zwitterionic phosphorylcholine (cas 107-73-3) polymers with aggregation-induced emission feature
Next:Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine (cas 107-73-3)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine (cas 107-73-3)08/26/2019
- ProtocolsBiocompatible zwitterionic phosphorylcholine (cas 107-73-3) polymers with aggregation-induced emission feature08/24/2019
- Optimisation of grafted phosphorylcholine (cas 107-73-3)-based polymer on additively manufactured titanium substrate for hip arthroplasty08/23/2019
- Layer by layer assembled phosphorylcholine (cas 107-73-3) groups on paclitaxel/chitosan nanofibers coatings for hemocompatibility improvement08/22/2019
- Bioinspired mimics: Self-assembly of redox-activated phosphorylcholine (cas 107-73-3)–based biodegradable copolymers for enhancing antitumor efficiency08/21/2019
- Regular ArticleBiodegradable phosphorylcholine (cas 107-73-3)-based zwitterionic polymer nanogels with smart charge-conversion ability for efficient inhibition of tumor cells08/20/2019
- Role of phosphorylcholine (cas 107-73-3) in Streptococcus pneumoniae and nontypeable Haemophilus influenzae adherence to epithelial cells☆08/19/2019
- The therapeutic potential of tuftsin-phosphorylcholine (cas 107-73-3) in giant cell arteritis08/18/2019